Recent advances in diagnostic and therapeutic methods in pediatric oncology have contributed to an 80 percent increase in survivorship. However, major long-term complications can occur that limit the quality of survival, including infertility. Treatments including chemotherapy, radiation therapy and surgery have been implicated as causes of infertility. With a goal of maximizing the survivor's quality of life, fertility preservation options for both prepubertal and pubescent males and females will be addressed.

This educational activity consists of recorded presentations from the 2010 Advances in the Management of Oncology Patients conference held in Scottsdale, Arizona on April 26-28, 2010. For more information on additional presentations from this event please go to, http://www.optumhealtheducation.com/cme/oncology/advances-in-the-management-of-oncology-patients.

Learning Objectives
At the end of this educational activity, participants should be able to

1. Fertility Preservation: Current Options to Protect Gametes From Toxic Therapies—What’s Available, What’s Reasonable
2. Discuss fertility preservation options that are available for both male and female cancer patients.

Presenter
David P. Cohen, MD
Associate Professor of Obstetrics/Gynecology
Chief, Reproductive Endocrinology and Infertility
University of Chicago Medical Center
Chicago, Illinois

Faculty Disclosures
As a sponsor accredited by the ACCME, the Institute for the Advancement of Human Behavior and the joint sponsor, OptumHealth Education requires the disclosure of any significant financial interest or other relationship a faculty member or sponsor has with the manufacturer(s) of any product discussed in this educational presentation. The faculty reported the following:

David P. Cohen, MD
Dr Cohen has indicated that he has no relevant financial relationships.
Dr Cohen does not intend to discuss unapproved/investigative use of commercial products/devices.

Disclosure of Unlabeled or Investigational Drugs
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Staff Disclosures
In compliance with the ACCME's Standards for Commercial Support, employees of OptumHealth Education who have control over content of a CME activity are required to disclose their relevant financial relationships. No employee has a relevant financial relationship regarding this activity.

Contact Information for Content, Website and/or CNE/CE Questions
OptumHealth Education
Phone: (800) 326-9166
E-mail: [email protected]

Contact Information for CME Credit Questions
Sheryl Morgan
Institute for the Advancement of Human Behavior
Phone: (651) 789-3730
E-mail: [email protected]

Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

To participate in this activity, begin by viewing the CE Info and then follow the prompts.

Sponsored By
This activity is jointly sponsored by the Institute for the Advancement of Human Behavior and OptumHealth Education.

Commercial Support
There was no commercial support received for this activity.

Hardware/Software Requirements
To view this Webcast you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software.

Please see our Privacy Policy by clicking here